Shares in vaccine makers and healthcare firms around the world slid sharply on Friday, as investors warned that Donald ...

GSK reported positive results from its phase three ‘DREAMM-7’ trial on Thursday, highlighting a significant overall survival ...

Critics believe Donald Trump's nominee to lead Health and Human Services poses a threat to the achievements of a ...

The awards are presented annually to organizations in the Greater Philadelphia and Triangle (North Carolina) regions.

The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to ...

GSK and Sanofi, the world’s two biggest vaccine makers by sales, both fell more than 3.5 per cent, while the nomination also hit the pharmaceutical sector more broadly, with a basket of European ...

UK drugmaker GSK might be trading lower following Thursday’s nomination of vaccine sceptic Robert F Kennedy Jr as the USA’s ...

Deutsche Bank downgraded GSK (GSK) to Hold from Buy with a price target of 1,350 GBp, down from 1,700 GBp. The firm cites President-elect ...

Robert F. Kennedy Jr.'s chance to head the Department of Health and Human Services vexes Jake Tapper: "I hope you like ...

Should Kennedy win Senate confirmation, critics say a radical antiestablishment medical movement would take power.

Leading companies in the functional foods market are concentrating on creating innovative products, including new plant-based ingredients, to enhance their market position. Plant ingredients are ...

AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...